ACHC
Acadia Healthcare Company Inc
NASDAQ: ACHC · HEALTHCARE · MEDICAL CARE FACILITIES
$25.01
-2.90% today
Updated 2026-06-05
Market cap
$2.14B
P/E ratio
—
P/S ratio
0.64x
EPS (TTM)
$-12.20
Dividend yield
—
52W range
$11 – $30
Volume
2.9M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
4.7
Growth
C4.5
Quality
C4.0
Profitability
C7.0
Valuation
B+4/9
Piotroski F-Score
Moderate
0.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$28.46
+13.79%
12-Month target
—
—
Intrinsic (DCF)
$96.47
Margin of safety
+83.90%
2 Strong Buy5 Buy6 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ 83.90% below intrinsic value
Risks
- Altman Z 0.29 — distress zone
- Thin margins at -32.80%
- Negative free cash flow $-15.03M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.61B | $2.93B | $3.15B | $3.31B | $3.37B |
| Net income | $273.14M | $-21.67M | $255.61M | $-1.10B | $4.11M |
| EPS | — | — | — | — | $-12.20 |
| Free cash flow | $84.42M | $38.21M | $-560.69M | $-439.91M | $-15.03M |
| Profit margin | 10.46% | -0.74% | 8.10% | -33.29% | -32.80% |
Peer comparison
Smart narrative
Acadia Healthcare Company Inc trades at $25.01. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.29, it sits in the distress. TTM revenue stands at $3.37B. with profit margins at -32.80%. Our DCF model estimates intrinsic value at $96.47.
Frequently asked questions
What is Acadia Healthcare Company Inc's stock price?
Acadia Healthcare Company Inc (ACHC) trades at $25.01, on a P/S of 0.6x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Acadia Healthcare Company Inc overvalued?
Acadia Healthcare Company Inc carries a Smart Value Score of 51/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $96.47 versus the $25.01 price, a 83.9% margin of safety on a cash flow basis.
What is the price target of Acadia Healthcare Company Inc (ACHC)?
The 12-month analyst consensus target is $28.46, about 13.8% above the current $25.01. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Acadia Healthcare Company Inc (ACHC)?
Our DCF model estimates intrinsic value at $96.47, a +83.9% margin of safety versus today's $25.01. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Acadia Healthcare Company Inc's revenue?
Acadia Healthcare Company Inc's trailing twelve-month revenue is $3.37B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Acadia Healthcare Company Inc's Altman Z-Score is 0.29, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.64x
ROE-56.53%
Beta0.73
50D MA$25.39
200D MA$20.70
Shares out0.09B
Float0.09B
Short ratio—
Avg volume2.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—